同和药业(300636.SZ)通过美国FDA现场检查

Core Viewpoint - The company, Tonghua Pharmaceutical (300636.SZ), has successfully passed the cGMP inspection conducted by the U.S. FDA, confirming compliance with U.S. drug production quality management standards [1] Group 1: Inspection Details - The cGMP inspection took place from August 4 to August 7, 2025, covering six major systems: quality system, materials, production, packaging and labeling, equipment facilities, and laboratory controls [1] - The company received confirmation from the U.S. FDA's official website that it has met the cGMP management standards [1]